Envestnet Asset Management
GTHX

Envestnet Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Envestnet Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,299
Closed -$80.5K – 4345
2024
Q2 		$80.5K Sell
35,299
-122
-0.3% -$466 ﹤0.01% 4076
2024
Q1 		$153K Buy
35,421
+7,740
+28% +$27K ﹤0.01% 4001
2023
Q4 		$84.4K Buy
27,681
+3,262
+13% +$6.13K ﹤0.01% 3958
2023
Q3 		$35.2K Buy
24,419
+4,526
+23% +$8.76K ﹤0.01% 3955
2023
Q2 		$49.5K Buy
19,893
+3,524
+22% +$9.63K ﹤0.01% 3870
2023
Q1 		$43.9K Buy
16,369
+5,976
+58% +$28.7K ﹤0.01% 3861
2022
Q4 		$56.4K Buy
+10,393
New +$87.1K ﹤0.01% 3858
2022
Q3 		– Sell
-10,772
Closed -$53K – 4066
2022
Q2 		$53K Buy
+10,772
New +$59.7K ﹤0.01% 3816

Envestnet Asset Management's GTHX Position: Q3 2024 in Review

Envestnet Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 35,299 shares — an estimated $80.5K sold.

Envestnet Asset Management first reported a position in GTHX in Q2 2022 and held it in 8 quarters. The position peaked at $153K in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Envestnet Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 35,299 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $80.5K.
  • Envestnet Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Envestnet Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $153K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Envestnet Asset Management's 13F filing for Q3 2024, filed 7 Nov 2024.